Cellosaurus cell line CH-01 (CVCL

Cross-references
Cell line name	CH-01
Synonyms	Clone 3; anti-CHRNB2 mAb-3
Accession	CVCL_C7NF
Resource Identification Initiative	To cite this cell line use: CH-01 (RRID:CVCL_C7NF)
Comments	Group: Patented cell line. Registration: International Depositary Authority, Japanese National Institute of Technology and Evaluation; NITE BP-02857. Monoclonal antibody isotype: Not specified. Monoclonal antibody target: UniProtKB; P17787; Human CHRNB2.
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy	Parent: CVCL_3412 (P3X63Ag8U.1)
Category	Hybridoma
Publications	PubMed=34331011; DOI=10.1038/s41388-021-01945-9 Kanda M., Shimizu D., Nakamura S., Sawaki K., Umeda S., Miwa T., Tanaka H., Inokawa Y., Hattori N., Hayashi M., Tanaka C., Nakayama G., Iguchi Y., Katsuno M., Kodera Y. Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells. Oncogene 40:5495-5504(2021) Patent=US20210040208 Kanda M. Therapeutic agent targeted to receptor protein, test agent, antibody that binds to receptor protein, and screening method for molecularly targeted drugs. Patent number US20210040208, 11-Feb-2021
Encyclopedic resources	Wikidata; Q117704239
Entry history
Entry creation	21-Mar-2023
Last entry update	29-Jun-2023
Version number	2